HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paranoid Disorders (Paranoia)

Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.
Also Known As:
Paranoia; Paranoias; Disorder, Paranoid; Disorders, Paranoid; Paranoid Disorder; Paranoid Psychoses; Psychoses, Paranoid
Networked: 396 relevant articles (16 outcomes, 33 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Psychotic Disorders (Schizoaffective Disorder)
2. Hallucinations (Hallucination)
3. Brain Diseases (Brain Disorder)
4. Cocaine-Related Disorders (Cocaine Addiction)
5. Phobic Disorders (Phobia)

Experts

1. Gelernter, Joel: 15 articles (06/2014 - 04/2002)
2. Freeman, Daniel: 14 articles (07/2022 - 05/2005)
3. Kranzler, Henry R: 11 articles (09/2011 - 07/2005)
4. Fowler, David: 8 articles (07/2022 - 05/2005)
5. Bebbington, Paul: 7 articles (07/2022 - 05/2005)
6. Emsley, Richard: 7 articles (07/2022 - 05/2015)
7. Kalayasiri, Rasmon: 7 articles (06/2019 - 02/2006)
8. Cubells, Joseph F: 7 articles (09/2011 - 02/2003)
9. Kuipers, Elizabeth: 6 articles (07/2022 - 05/2005)
10. Dunn, Graham: 6 articles (01/2022 - 05/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Paranoid Disorders:
1. Antipsychotic Agents (Antipsychotics)IBA
2. N 30IBA
3. Cocaine (Cocaine HCl)IBA
4. Methamphetamine (Desoxyn)FDA LinkGeneric
5. metariboadenosine triphosphorousIBA
6. SaltsIBA
7. Olanzapine (Zyprexa)FDA Link
8. Antidepressive Agents (Antidepressants)IBA
09/01/1983 - "A clinical report of thymoleptic-responsive atypical paranoid psychoses."
09/01/1983 - "The paranoid disorders of five patients remitted after treatment with thymoleptic agents despite the absence of a full affective syndrome. "
03/01/2021 - "Upon treatment with CBD and cessation of the antidepressant medication, the patient improved regarding depressive as well as anxiety symptoms including simple phobias and symptoms of paranoia and dissociation. "
11/05/2021 - "Finally, Rivas-Grajales and colleagues described a 52-year-old woman with recurrent TRD and chronic migraines who was receiving 2 antidepressants and migraine medication, who presented emergently with agitation and paranoia in the context of receiving intranasal ketamine from multiple providers, suggesting a pattern of misuse. "
08/03/2022 - "Factors found more among BD-2 > BD-1 cases included: [a] descriptors (more familial affective disorder, older at onset, diagnosis and first-treatment, more education, employment and higher socioeconomic status, more marriage and children, and less obesity); [b] morbidity (more general medical diagnoses, less drug abuse and smoking, more initial depression and less [hypo]mania or psychosis, longer episodes, higher intake depression and anxiety ratings, less mood-switching with antidepressants, less seasonal mood-change, greater %-time depressed and less [hypo]manic, fewer hospitalizations, more depression-predominant polarity, DMI > MDI course-pattern, and less violent suicidal behavior); [c] specific item-scores with initial HDRS21 (higher scores for depression, guilt, suicidality, insomnia, anxiety, agitation, gastrointestinal symptoms, hypochondriasis and weight-loss, with less psychomotor retardation, depersonalization, or paranoia); and [d] treatment (less use of lithium or antipsychotics, more antidepressant and benzodiazepine treatment). "
9. Phenelzine (Nardil)FDA Link
10. Imipramine (Janimine)FDA LinkGeneric

Therapies and Procedures

1. Therapeutics
2. Institutionalization (Institutionalized Persons)
3. Transcranial Direct Current Stimulation
4. Self Medication
5. Behavior Control